NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 160 filers reported holding NEVRO CORP in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,586 | -63.2% | 101,729 | -47.7% | 0.01% | -66.7% |
| Q1 2023 | $7,035 | -7.6% | 194,592 | +1.2% | 0.02% | -11.1% |
| Q4 2022 | $7,611 | -99.9% | 192,194 | -3.5% | 0.03% | -27.0% |
| Q3 2022 | $9,282,000 | +21.2% | 199,187 | +14.0% | 0.04% | +27.6% |
| Q2 2022 | $7,656,000 | -35.6% | 174,683 | +6.3% | 0.03% | -29.3% |
| Q1 2022 | $11,881,000 | -17.8% | 164,263 | -7.8% | 0.04% | -14.6% |
| Q4 2021 | $14,447,000 | -28.9% | 178,201 | +2.1% | 0.05% | -36.0% |
| Q3 2021 | $20,306,000 | -52.2% | 174,482 | -32.0% | 0.08% | -50.7% |
| Q2 2021 | $42,515,000 | +64.4% | 256,441 | +38.3% | 0.15% | +42.1% |
| Q1 2021 | $25,866,000 | – | 185,417 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |